Koesten Hirschmann & Crabtree’s Compugen CGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding CGEN
SCM
NAMI
TFCM
YLHM
SCM
Koesten Hirschmann & Crabtree's CGEN Position: Q4 2025 in Review
Koesten Hirschmann & Crabtree sold out of Compugen (CGEN) in Q4 2025, closing a stake of 100 shares — an estimated $147 sold.
Koesten Hirschmann & Crabtree first reported a position in CGEN in Q4 2024 and held it in 4 quarters. The position peaked at $178 in Q2 2025. 72 funds tracked by Wall St. Rank hold CGEN as of Q4 2025.
- Koesten Hirschmann & Crabtree reported no remaining Compugen position as of Q4 2025 after selling out during the quarter.
- Koesten Hirschmann & Crabtree sold 100 Compugen shares in Q4 2025, an estimated $147.
- Koesten Hirschmann & Crabtree first reported a position in Compugen in Q4 2024 and held it in 4 quarters.
- Koesten Hirschmann & Crabtree's Compugen position peaked at $178 in Q2 2025.
- 72 funds tracked by Wall St. Rank held Compugen as of Q4 2025.
Based on Koesten Hirschmann & Crabtree's 13F filing for Q4 2025, filed 9 Feb 2026.